ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,515Medicare Part D Prescriptions Filled, Including Refills

Rank: 238 out of 3734

$698K Total Retail Price of All Prescriptions

Rank: 316 out of 3734

504 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 504 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 504 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 10,954 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 701 606 1 1
OMEPRAZOLE 633 528 2 4
LEVOTHYROXINE SODIUM 569 486 3 2
ATENOLOL 564 432 4 13
AMLODIPINE BESYLATE 458 423 5 5
LISINOPRIL 456 432 6 3
FUROSEMIDE 414 369 7 7
METFORMIN HCL 391 297 8 8
METOPROLOL TARTRATE 359 327 9 6
CITALOPRAM HBR 274 188 10 16
TRAMADOL HCL 252 136 11 20
ENALAPRIL MALEATE 210 188 12 63
WARFARIN SODIUM 184 131 13 10
LOSARTAN POTASSIUM 166 163 14 21
POTASSIUM CHLORIDE 162 124 15 19
GLYBURIDE 159 125 R 16 64
ATORVASTATIN CALCIUM 155 133 17 11
PANTOPRAZOLE SODIUM 141 131 18 22
PRAVASTATIN SODIUM 124 78 19 15
RANITIDINE HCL 113 66 20 32
CRESTOR 109 108 21 28
OXYBUTYNIN CHLORIDE ER 107 82 22 141
CLOPIDOGREL 104 97 23 23
HYDROCODONE-ACETAMINOPHEN 102 25 S3 24 12
MIRTAZAPINE 100 84 25 45
DIOVAN 96 96 26 31
HYDROCHLOROTHIAZIDE 95 82 27 9
HYDRALAZINE HCL 92 89 28 111
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 81 28 27
ACETAMINOPHEN-CODEINE 92 65 S3 28 123
LOSARTAN-HYDROCHLOROTHIAZIDE 86 75 31 71
ADVAIR DISKUS 83 67 32 35
METOPROLOL SUCCINATE 83 83 32 14
ALLOPURINOL 82 74 34 33
ZOLPIDEM TARTRATE 81 49 35 24
GABAPENTIN 81 62 35 17
CARVEDILOL 77 77 37 30
FLUTICASONE PROPIONATE 77 44 37 46
DONEPEZIL HCL 76 68 39 25
NEXIUM 76 76 39 36
POLYETHYLENE GLYCOL 3350 73 59 41 53
SERTRALINE HCL 72 60 42 18
LANTUS 70 58 43 54
CELEBREX 69 60 44 69
AZITHROMYCIN 66 53 45 38
NIFEDIPINE ER 65 65 46 113
CARBIDOPA-LEVODOPA 65 62 46 92
PLAVIX 63 58 48 39
NAMENDA 63 63 48 44
JANUMET 62 50 50 180
FINASTERIDE 62 62 50 88
OXYCODONE-ACETAMINOPHEN 60 39 S2 52 51
GLIPIZIDE 59 51 53 57
LABETALOL HCL 57 52 54 176
RISPERIDONE 55 29 55 62
ISOSORBIDE MONONITRATE ER 55 51 55 34
SPIRIVA 54 54 57 40
TERAZOSIN HCL 54 54 57 136
TOPIRAMATE 54 12 57 181
TRIAMCINOLONE ACETONIDE 53 48 60 131
IBUPROFEN 52 35 61 75
PROAIR HFA 51 51 62 83
SYNTHROID 51 51 62 47
VENLAFAXINE HCL ER 51 25 62 84
JANTOVEN 51 51 62 76
FENTANYL 51 21 S2 62 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.